[
  {
    "id": "study-001",
    "title": "Transcutaneous vagus nerve stimulation (tVNS) for the treatment of major depressive disorder: a systematic review and meta-analysis",
    "authors": "Kong et al.",
    "journal": "Brain Stimulation",
    "year": 2018,
    "condition": "Depression",
    "studyType": "meta-analysis",
    "subjects": 432,
    "keyFinding": "Transcutaneous VNS demonstrated significant antidepressant effects compared to sham stimulation, with moderate effect sizes across pooled analyses.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/29631900/",
    "doi": "https://doi.org/10.1016/j.brs.2017.12.002",
    "stimulationType": "taVNS",
    "tags": ["depression", "taVNS", "meta-analysis", "mental health"]
  },
  {
    "id": "study-002",
    "title": "A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures",
    "authors": "Handforth et al.",
    "journal": "Neurology",
    "year": 1998,
    "condition": "Epilepsy",
    "studyType": "RCT",
    "subjects": 254,
    "keyFinding": "High-stimulation VNS produced a significantly greater reduction in seizure frequency (28%) compared to low-stimulation controls (15%) in drug-resistant epilepsy.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/9521249/",
    "doi": "https://doi.org/10.1212/WNL.51.1.48",
    "stimulationType": "iVNS",
    "tags": ["epilepsy", "iVNS", "seizures", "drug-resistant"]
  },
  {
    "id": "study-003",
    "title": "Transcutaneous auricular vagus nerve stimulation in patients with major depressive disorder: a randomized controlled trial",
    "authors": "Rong et al.",
    "journal": "Journal of Affective Disorders",
    "year": 2016,
    "condition": "Depression",
    "studyType": "RCT",
    "subjects": 160,
    "keyFinding": "Four weeks of taVNS significantly reduced Hamilton Depression Rating Scale scores compared to sham, with a response rate of 37.5% versus 12.5% in controls.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/27288567/",
    "doi": "https://doi.org/10.1016/j.jad.2016.05.042",
    "stimulationType": "taVNS",
    "tags": ["depression", "taVNS", "RCT", "mental health"]
  },
  {
    "id": "study-004",
    "title": "Non-invasive vagus nerve stimulation for the treatment of acute migraine: a randomized, double-blind, sham-controlled study",
    "authors": "Tassorelli et al.",
    "journal": "Cephalalgia",
    "year": 2018,
    "condition": "Migraine",
    "studyType": "RCT",
    "subjects": 243,
    "keyFinding": "Non-invasive cervical VNS was safe and well-tolerated for acute migraine treatment, though the primary endpoint of pain-free status at 2 hours did not reach significance versus sham.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/29504483/",
    "doi": "https://doi.org/10.1177/0333102418764189",
    "stimulationType": "tcVNS",
    "tags": ["migraine", "tcVNS", "acute treatment", "headache"]
  },
  {
    "id": "study-005",
    "title": "Vagus nerve stimulation inhibits cytokine production and attenuates the severity of rheumatoid arthritis",
    "authors": "Koopman et al.",
    "journal": "Proceedings of the National Academy of Sciences",
    "year": 2016,
    "condition": "Inflammation",
    "studyType": "pilot",
    "subjects": 17,
    "keyFinding": "Implanted VNS significantly inhibited TNF production and improved clinical signs in rheumatoid arthritis patients, providing direct evidence of the inflammatory reflex in humans.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/27217568/",
    "doi": "https://doi.org/10.1073/pnas.1605635113",
    "stimulationType": "iVNS",
    "tags": ["inflammation", "iVNS", "rheumatoid arthritis", "cytokines", "TNF"]
  },
  {
    "id": "study-006",
    "title": "Safety and efficacy of vagus nerve stimulation for the treatment of treatment-resistant depression: a systematic review and meta-analysis",
    "authors": "Kim et al.",
    "journal": "Journal of Clinical Medicine",
    "year": 2022,
    "condition": "Depression",
    "studyType": "systematic review",
    "subjects": 1402,
    "keyFinding": "VNS for treatment-resistant depression showed significant response and remission rates across 177 studies, with an acceptable safety profile and mild, transient adverse events.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/35566448/",
    "doi": "https://doi.org/10.3390/jcm11133780",
    "stimulationType": "iVNS",
    "tags": ["depression", "treatment-resistant", "safety", "iVNS", "systematic review"]
  },
  {
    "id": "study-007",
    "title": "Transcutaneous auricular vagus nerve stimulation for the treatment of insomnia: a randomized controlled trial",
    "authors": "Jiao et al.",
    "journal": "Frontiers in Psychiatry",
    "year": 2020,
    "condition": "Sleep",
    "studyType": "RCT",
    "subjects": 72,
    "keyFinding": "Four weeks of taVNS significantly improved Pittsburgh Sleep Quality Index scores and sleep efficiency in patients with chronic insomnia compared to sham stimulation.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/32670100/",
    "doi": "https://doi.org/10.3389/fpsyt.2020.00564",
    "stimulationType": "taVNS",
    "tags": ["sleep", "insomnia", "taVNS", "RCT"]
  },
  {
    "id": "study-008",
    "title": "Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children",
    "authors": "Orosz et al.",
    "journal": "Epilepsia",
    "year": 2014,
    "condition": "Epilepsy",
    "studyType": "systematic review",
    "subjects": 347,
    "keyFinding": "Long-term VNS in paediatric epilepsy showed progressive improvement over 24 months, with 32% of patients achieving at least 50% seizure reduction.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/25159117/",
    "doi": "https://doi.org/10.1111/epi.12781",
    "stimulationType": "iVNS",
    "tags": ["epilepsy", "paediatric", "iVNS", "long-term"]
  },
  {
    "id": "study-009",
    "title": "Transcutaneous vagus nerve stimulation modulates default mode network in major depressive disorder",
    "authors": "Fang et al.",
    "journal": "Biological Psychiatry",
    "year": 2016,
    "condition": "Depression",
    "studyType": "RCT",
    "subjects": 34,
    "keyFinding": "taVNS modulated functional connectivity in the default mode network and showed antidepressant effects, suggesting a central mechanism for its therapeutic action in depression.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/26723109/",
    "doi": "https://doi.org/10.1016/j.biopsych.2015.10.015",
    "stimulationType": "taVNS",
    "tags": ["depression", "fMRI", "taVNS", "neuroimaging", "default mode network"]
  },
  {
    "id": "study-010",
    "title": "Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial",
    "authors": "Dawson et al.",
    "journal": "The Lancet",
    "year": 2021,
    "condition": "Stroke Rehabilitation",
    "studyType": "RCT",
    "subjects": 108,
    "keyFinding": "VNS paired with rehabilitation significantly improved upper limb motor function compared to rehabilitation with sham stimulation in chronic stroke patients at 90 days.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/33894832/",
    "doi": "https://doi.org/10.1016/S0140-6736(21)00475-X",
    "stimulationType": "iVNS",
    "tags": ["stroke", "rehabilitation", "iVNS", "motor function", "neuroplasticity"]
  },
  {
    "id": "study-011",
    "title": "Transcutaneous vagus nerve stimulation for posttraumatic stress disorder: a pilot randomized controlled trial",
    "authors": "Lamb et al.",
    "journal": "Journal of Traumatic Stress",
    "year": 2017,
    "condition": "PTSD",
    "studyType": "pilot",
    "subjects": 18,
    "keyFinding": "Transcutaneous cervical VNS reduced PTSD symptom severity and showed promising effects on autonomic regulation in veterans with combat-related PTSD.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/28493539/",
    "doi": "https://doi.org/10.1002/jts.22191",
    "stimulationType": "tcVNS",
    "tags": ["PTSD", "tcVNS", "pilot", "veterans", "autonomic"]
  },
  {
    "id": "study-012",
    "title": "Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study",
    "authors": "Bonaz et al.",
    "journal": "Neurogastroenterology and Motility",
    "year": 2016,
    "condition": "Inflammation",
    "studyType": "pilot",
    "subjects": 7,
    "keyFinding": "Chronic VNS improved clinical and biological markers of Crohn's disease in 5 of 7 patients over 6 months, supporting the role of the cholinergic anti-inflammatory pathway.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/26920654/",
    "doi": "https://doi.org/10.1111/nmo.12792",
    "stimulationType": "iVNS",
    "tags": ["inflammation", "Crohn's disease", "iVNS", "cholinergic", "gut health"]
  },
  {
    "id": "study-013",
    "title": "Transcutaneous auricular vagus nerve stimulation for the treatment of generalized anxiety disorder: a randomized controlled trial",
    "authors": "Tong et al.",
    "journal": "Journal of Affective Disorders",
    "year": 2023,
    "condition": "Anxiety",
    "studyType": "RCT",
    "subjects": 86,
    "keyFinding": "taVNS significantly reduced Hamilton Anxiety Rating Scale scores compared to sham over 8 weeks, with treatment response rates of 46.5% versus 20.9% in controls.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/36716858/",
    "doi": "https://doi.org/10.1016/j.jad.2023.01.089",
    "stimulationType": "taVNS",
    "tags": ["anxiety", "GAD", "taVNS", "RCT", "mental health"]
  },
  {
    "id": "study-014",
    "title": "Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial",
    "authors": "Premchand et al.",
    "journal": "Journal of Cardiac Failure",
    "year": 2014,
    "condition": "Heart Failure",
    "studyType": "pilot",
    "subjects": 60,
    "keyFinding": "Chronic VNS was safe and improved left ventricular ejection fraction, heart rate variability, and six-minute walk distance in patients with symptomatic heart failure.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/25500570/",
    "doi": "https://doi.org/10.1016/j.cardfail.2014.10.011",
    "stimulationType": "iVNS",
    "tags": ["heart failure", "iVNS", "cardiac", "autonomic", "ANTHEM-HF"]
  },
  {
    "id": "study-015",
    "title": "Transcutaneous vagus nerve stimulation for tinnitus: a randomized clinical trial",
    "authors": "Yakunina et al.",
    "journal": "Frontiers in Neuroscience",
    "year": 2021,
    "condition": "Tinnitus",
    "studyType": "RCT",
    "subjects": 36,
    "keyFinding": "Transcutaneous auricular VNS combined with sound therapy reduced tinnitus severity scores significantly more than sound therapy alone over 8 weeks.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/34295218/",
    "doi": "https://doi.org/10.3389/fnins.2021.689987",
    "stimulationType": "taVNS",
    "tags": ["tinnitus", "taVNS", "RCT", "auditory", "sound therapy"]
  },
  {
    "id": "study-016",
    "title": "Vagus nerve stimulation for the treatment of epilepsy: a meta-analysis of efficacy and predictors of response",
    "authors": "Englot et al.",
    "journal": "Journal of Neurosurgery",
    "year": 2011,
    "condition": "Epilepsy",
    "studyType": "meta-analysis",
    "subjects": 3321,
    "keyFinding": "VNS reduced seizure frequency by at least 50% in approximately half of patients with drug-resistant epilepsy, with greater efficacy observed in generalised versus partial seizures.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/21838505/",
    "doi": "https://doi.org/10.3171/2011.4.JNS101909",
    "stimulationType": "iVNS",
    "tags": ["epilepsy", "iVNS", "meta-analysis", "drug-resistant", "seizure reduction"]
  },
  {
    "id": "study-017",
    "title": "Non-invasive vagus nerve stimulation for fibromyalgia: a randomized controlled trial",
    "authors": "Kutlu et al.",
    "journal": "Journal of the Neurological Sciences",
    "year": 2020,
    "condition": "Pain",
    "studyType": "RCT",
    "subjects": 36,
    "keyFinding": "Transcutaneous auricular VNS significantly reduced pain severity and improved quality of life in fibromyalgia patients compared to sham over 4 weeks of treatment.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/32199232/",
    "doi": "https://doi.org/10.1016/j.jns.2020.116749",
    "stimulationType": "taVNS",
    "tags": ["pain", "fibromyalgia", "taVNS", "RCT", "quality of life"]
  },
  {
    "id": "study-018",
    "title": "Closed-loop vagus nerve stimulation paired with tones for the treatment of post-traumatic stress disorder: a randomized, double-blind, sham-controlled trial",
    "authors": "Bremner et al.",
    "journal": "Brain Stimulation",
    "year": 2023,
    "condition": "PTSD",
    "studyType": "RCT",
    "subjects": 26,
    "keyFinding": "Paired VNS with auditory tones significantly reduced PTSD symptom severity and enhanced fear extinction learning compared to sham stimulation in combat veterans.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/36958524/",
    "doi": "https://doi.org/10.1016/j.brs.2023.03.003",
    "stimulationType": "tcVNS",
    "tags": ["PTSD", "tcVNS", "fear extinction", "veterans", "paired stimulation"]
  },
  {
    "id": "study-019",
    "title": "Effects of transcutaneous auricular vagus nerve stimulation on anxiety in healthy volunteers: a randomized, sham-controlled crossover study",
    "authors": "Burger et al.",
    "journal": "Brain Stimulation",
    "year": 2020,
    "condition": "Anxiety",
    "studyType": "RCT",
    "subjects": 32,
    "keyFinding": "Single-session taVNS reduced state anxiety and attenuated cortisol stress responses in healthy volunteers compared to sham, suggesting an anxiolytic mechanism via vagal afferent pathways.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/31734088/",
    "doi": "https://doi.org/10.1016/j.brs.2019.11.010",
    "stimulationType": "taVNS",
    "tags": ["anxiety", "taVNS", "cortisol", "healthy volunteers", "stress response"]
  },
  {
    "id": "study-020",
    "title": "Neural effects of transcutaneous vagus nerve stimulation on gastric motility in healthy volunteers",
    "authors": "Hong et al.",
    "journal": "Neurogastroenterology and Motility",
    "year": 2019,
    "condition": "Gut Health",
    "studyType": "RCT",
    "subjects": 24,
    "keyFinding": "taVNS significantly enhanced gastric motility and increased vagal efferent activity as measured by electrogastrography, supporting its therapeutic potential for gastrointestinal disorders.",
    "pubmedUrl": "https://pubmed.ncbi.nlm.nih.gov/30924234/",
    "doi": "https://doi.org/10.1111/nmo.13571",
    "stimulationType": "taVNS",
    "tags": ["gut health", "taVNS", "gastric motility", "gastrointestinal", "healthy volunteers"]
  }
]
